Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders

Genes, Brain and Behavior

Volumn 2, Issue 6, 2003, Pages 350-364

  Murphy, D L ^a,f   Uhl, G R ^b   Holmes, A ^c   Ren Patterson, R ^a   Hall, F S ^b   Sora, I ^d   Detera Wadleigh, S ^a   Lesch, K P ^e  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

BDNF; Complex genetics; DAT; Endopheno types; Knockout mice; MAO; NET; Serotonin transporter

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN 1B RECEPTOR; SEROTONIN TRANSPORTER;

BEHAVIOR GENETICS; CORRELATION ANALYSIS; DEVELOPMENTAL DISORDER; GENE EXPRESSION; GENE INTERACTION; GENETIC COMPLEMENTATION; GENETIC DISORDER; GENETIC EPISTASIS; GENETIC MODEL; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; KNOCKOUT MOUSE; MORPHOLOGICAL TRAIT; MOUSE MUTANT; NEUROANATOMY; NEUROCHEMISTRY; NEUROPSYCHIATRY; NONHUMAN; OBESITY; PHENOTYPIC VARIATION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN VARIANT; QUANTITATIVE TRAIT; REVIEW; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENVIRONMENT; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; QUANTITATIVE TRAIT LOCI; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYMPORTERS;

MUS MUSCULUS;

EID: 0345305851     PISSN: 16011848     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1601-1848.2003.00049.x     Document Type: Review

References (136)

1. Abdel-Majid, R.M., Leong, W.L., Schalkwyk, L.C., Smallman, D.S., Wong, S.T., Storm, D.R., Fine, A., Dobson, M.J., Guernsey, D.L. & Neumann, P.E. (1998) Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex. Nat Genet 19, 289-291.
2. Alvarez, C., Vitalis, T., Fon, E.A., Hanoun, N., Hamon, M., Seif, I., Edwards, R., Gaspar, P. & Cases, O. (2002) Effects of genetic depletion of monoamines on somatosensory cortical development. Neuroscience 115, 753-764.
3. Anguelova, M., Benkelfat, C. & Turecki, G. (2003) A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter. I. Affective disorders. Mol Psychiatry 8, 574-591.
4. Bae, K., Jin, X., Maywood, E.S., Hastings, M.H., Reppert, S.M. & Weaver, D.R. (2001) Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 30, 525-536.
5. Bale, T.L., Davis, A.M., Auger, A.P., Dorsa, D.M. & McCarthy, M.M. (2001) CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 21, 2546-2552.
6. Bale, T.L., Picetti, R., Contarino, A., Koob, G.F., Vale, W.W. & Lee, K.F. (2002) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 22, 193-199.
7. Bates, G. (2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642-1644.
8. Bateson, W. (1909) Mendel's Principles of Heredity. Cambridge University Press, Cambridge.
9. Bateson, W., Saunders, F.R., Punnett, R.C. & Hurst, C.C. (1905) Reports to the Evolution Committee of the Royal Society. Report II. Harrison and Sons, London.
10. Bengel, D., Greenberg, B.D., Corá-Locatelli, G., Altemus, M., Heils, A., Li, Q. & Murphy, D.L. (1999) Association of the serotonin transporter promoter regulatory region and obsessive-compulsive disorder. Mol Psychiatry 4, 463-466.
11. Bengel, D., Murphy, D.L., Andrews, A.M., Wichems, C.H., Feltner, D., Heils, A., Mossner, R., Westphal, H. & Lesch, K.P. (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4- methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Mol Pharmacol 53, 649-655.
12. Blows, M.W. & Sokolowski, M.B. (1995) The expression of additive and nonadditive genetic variation under stress. Genetics 140, 1149-1159.
13. Bosse, R., Fumagalli, F., Jaber, M., Giros, B., Gainetdinov, R.R., Wetsel, W.C., Missale, C. & Caron, M.G. (1997) Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19, 127-138.
14. Brunner, H.G., Nelen, M., Breakefield, X.O., Ropers, H.H. & van Oost, B.A. (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580.
15. Bucan, M. & Abel, T. (2002) The mouse: genetics meets behaviour. Nat Rev Genet 3, 114-123.
16. Butler, A.A. & Cone, R.D. (2001) Knockout models resulting in the development of obesity. Trends Genet 17, S50-S54.
17. Cases, O., Vitalis, T., Seif, I., De Maeyer, E., Sotelo, C. & Gaspar, P. (1996) Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16, 297-307.
18. Caspi, A., McClay, J., Moffitt, T.E., Mill, J., Martin, J., Craig, I.W., Taylor, A. & Poulton, R. (2002) Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854.
19. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A. & Poulton, R. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301,386-389.
20. Cepeda, C., Hurst, R.S., Calvert, C.R., Hernandez-Echeagaray, E., Nguyen, O.K., Jocoy, E., Christian, L.J., Ariano, M.A. & Levine, M.S. (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 23, 961-969.
21. Chen, J.J., Li, Z., Pan, H., Murphy, D.L., Tamir, H., Koepsell, H. & Gershon, M.D. (2001) Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter. Abnormal intestinal motility and the expression of cation transporters. J Neurosci 21, 6348-6361.
22. Cheverud, J.M. & Routman, E.J. (1995) Epistasis and its contribution to genetic variance components. Genetics 139, 1455-1461.
23. Collins, F.A., Murphy, D.L., Reiss, A.L., Sims, K.B., Lewis, J.G., Freund, L., Karoum, F., Zhu, D., Maumenee, I.H. & Antonarakis, S.E. (1992) Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am J Med Genet 42, 127-134.
24. Cordell, H.J. (2002) Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 11, 2463-2468.
25. Cryns, K., Van Spaendonck, M.P., Flothmann, K., van Alphen, A.M., Van De Heyning, P.H., Timmermans, J.P., De Zeeuw, C.I. & Van Camp, G. (2002) Vestibular dysfunction in the epistatic circler mouse is caused by phenotypic interaction of one recessive gene and three modifier genes. Genome Res 12, 613-617.
26. Daszuta, A. & Barrit, M.C. (1982) Endogenous serotonin (5-HT) and 5-hydroxyindole acetic acid (5-HIAA) levels in large regions and in discrete brain areas of C57BL and BALBc mice at three times of the day. Brain Res Bull 8, 477-482.
27. Deckert, J., Catalano, M., Syagailo, Y.V., Bosi, M., Okladnova, O., Di Bella, D., Nothen, M.M., Maffei, P., Franke, P., Fritze, J., Maier, W., Propping, P., Beckmann, H., Bellodi, L. & Lesch, K.P. (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8, 621-624.
28. Dewachter, I., Moechars, D., van Dorpe, J., Tesseur, I., Van den Haute, C., Spittaels, K. & Van Leuven, F. (2001) Modelling Alzheimer's disease in multiple transgenic mice. Biochem Soc Symp 67, 203-10.
29. Dluzen, D.E., Gao, X., Story, G.M., Anderson, L.I., Kucera, J. & Walro, J.M. (2001) Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp Neurol 170, 121-128.
30. Dluzen, D.E., Story, G.M., Xu, K., Kucera, J. & Walro, J.M. (1999) Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp Neurol 160, 500-507.
31. Dupuis, J., Brown, P.O. & Siegmund, D. (1995) Statistical methods for linkage analysis of complex traits from high-resolution maps of identity by descent. Genetics 140, 843-856.
32. Eaton, M.J., Staley, J.K., Globus, M.Y. & Whittemore, S.R. (1995) Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. Dev Biol 170, 169-182.
33. Epstein, L.H., Jaroni, J.L., Paluch, R.A., Leddy, J.J., Vahue, H.E., Hawk, L., Wileyto, E.P., Shields, P.G. & Lerman, C. (2002) Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res 10, 1232-1240.
34. Ernfors, P., Lee, K.F. & Jaenisch, R. (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147-150.
35. Esaki, T., Cook, M., Holmes, A., Shimoji, K., Murphy, D.L. & Sokoloff, L. (2002) American College of Neuropsychopharmacology Annual Metting. Science Abstracts, San Juan, Puerto Rico 41, 147.
36. Espinosa, F., McMahon, A., Chan, E., Wang, S., Ho, C.S., Heintz, N. & Joho, R.H. (2001) Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3. J Neurosci 21, 6657-6665.
37. Evrard, A., Malagie, I., Laporte, A.M., Boni, C., Hanoun, N., Trillat, A.C., Seif, I., De Maeyer, E., Gardier, A., Hamon, M. & Adrien, J. (2002) Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur J Neurosci 15, 841-851.
38. 1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12, 2299-2310.
39. Felner, A.E. & Waldmeier, P.C. (1979) Cumulative effects of irreversible MAO inhibitors in vivo. Biochem Pharmacol 28, 995-1002.
40. Fisher, R.A. (1918) The correlations between relatives on the supposition of Mendelian inheritance. Trans R Soc Edinburgh 52, 399-433.
41. Frankel, W.N. & Schork, N.J. (1996) Who's afraid of epistasis? Nat Genet 14, 371-373.
42. Friedman, J.M. & Leibel, R.L. (1992) Tackling a weighty problem. Cell 69, 217-220.
43. Galter, D. & Unsicker, K. (2000) Brain-derived neurotrophic factor and trkB are essential for cAMP-mediated induction of the serotonergic neuronal phenotype. J Neurosci Res 61, 295-301.
44. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. & Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
45. Gobbi, G., Murphy, D.L., Lesch, K.-P. & Blier, P. (2001) Modifications of the serotoninergic system in mice lacking serotonin transporters. An in vivo eletrophysiological study. J Pharmacol Exp Ther 296, 987-995.
46. Greenberg, B.D., Ziemann, U., Cora-Locatelli, G., Harmon, A., Murphy, D.L. & Keel, J.C., Wassermann, E.M. (2000) Altered cortical excitability in obsessive-compulsive disorder. Neurology 54, 142-147.
47. Hahn, M.K. & Blakely, R.D. (2002) Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2, 217-235.
48. Hall, D., Dhilla, A., Charalambous, A., Gogos, J.A. & Karayiorgou, M. (2003a) Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73, 370-376.
49. Hall, F.S., Drgonova, J., Goeb, M. & Uhl, G.R. (2003b) Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28, 1485-1490.
50. Hall, F.S., Li, X.F., Sora, I., Xu, F., Caron, M., Lesch, K.P., Murphy, D.L. & Uhl, G.R. (2002) Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115, 153-161.
51. Halpern, A. & Mancini, M.C. (2003) Treatment of obesity: an update on anti-obesity medications. Obes Rev 4, 25-42.
52. Heisler, L.K., Cowley, M.A., Tecott, L.H., Fan, W., Low, M.J., Smart, J.L., Rubinstein, M., Tatro, J.B., Marcus, J.N., Holstege, H., Lee, C.E., Cone, R.D. & Elmquist, J.K. (2002) Activation of central melanocortin pathways by fenfluramine. Science 297, 609-611.
53. Hinney, A., Barth, N., Ziegler, A., von Prittwitz, S., Hamann, A., Hennighausen, K., Pirke, K.M., Heils, A., Rosenkranz, K., Roth, H., Coners, H., Mayer, H., Herzog, W., Siegfried, A., Lehmkuhl, G., Poustka, F., Schmidt, M.H., Schafer, H., Grzeschik, K.H., Lesch, K.P., Lentes, K.U., Remschmidt, H. & Hebebrand, J. (1997) Serotonin transporter gene-linked polymorphic region: allele distributions in relationship to body weight and in anorexia nervosa. Life Sci 61, PL 295-303.
54. Hoh, J. & Ott, J. (2003) Mathematical multi-locus approaches to localizing complex human trait genes. Nat Rev Genet4, 701-709.
55. Holmes, A., Murphy, D.L. & Crawley, J.N. (2002a) Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161, 160-167.
56. Holmes, A., Yang, R.J., Murphy, D.L. & Crawley, J.N. (2002b) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27, 914-923.
57. Hood, H.M., Belknap, J.K., Crabbe, J.C. & Buck, K.J. (2001) Genomewide search for epistasis in a complex trait: pentobarbital withdrawal convulsions in mice. Behav Genet 31, 93-100.
58. Kendler, K.S. (2001) Twin studies of psychiatric illness: an update. Arch General Psychiatry 58, 1005-1014.
59. Kernie, S.G., Liebl, D.J. & Parada, L.F. (2000) BDNF regulates eating behavior and locomotor activity in mice. Embo J 19, 1290-1300.
60. Kilic, F., Murphy, D.L. & Rudnick, G. (2003) A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64, 440-446.
61. Kooy, R.F. (2003) of mice and the fragile X syndrome. Trends Genet 19, 148-154.
62. Korte, S.M., de Boer, S.F., de Kloet, E.R. & Bohus, B. (1995) Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 20, 385-394.
63. Lenders, J.W., Brunner, H.G., Murphy, D.L. & Eisenhofer, G. (1998) Genetic deficiencies of monoamine oxidase enzymes: a key to understanding the function of the enzymes in humans. Adv Pharmacol 42, 297-301.
64. Lesch, K.-P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H. & Murphy, D.L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
65. Li, Q., Wichems, C., Heils, A., Lesch, K.-P. & Murphy, D.L. (2000) Reduction in the density and expression, but not G protein coupling of 5-HT1A receptors in 5-HT transporter knockout mice: gender and brain region differences. J Neurosci 20, 7888-7895.
66. Li, Q., Wichems, C., Heils, A., Van De Kar, L.D., Lesch, K.P. & Murphy, D.L. (1999) Reduction of 5-hydroxytryptamine (5-HT) (1A)-mediated temperature and neuroendocrine responses and 5-HT (1A) binding sites in 5-HT transporter knockout mice. J Pharmacol Exp Ther 291, 999-1007.
67. Li, Q., Wichems, C., Ma, L., Van de Kar, L.D., Garcia, F. & Murphy, D.L. (2003) Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knock-out mice. J Neurochem 84, 1256-1265.
68. Liu, M.T., Rayport, S., Jiang, Y., Murphy, D.L. & Gershon, M.D. (2002) Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter. Am J Physiol Gastrointest Liver Physiol 283, G1398-G1411.
69. Long, A.D., Mullaney, S.L., Reid, L.A., Fry, J.D., Langley, C.H. & Mackay, T.F. (1995) High resolution mapping of genetic factors affecting abdominal bristle number in Drosophila melanogaster. Genetics 139, 1273-1291.
70. Lu, H.C., She, W.C., Plas, D.T., Neumann, P.E., Janz, R. & Crair, M.C. (2003) Adenylyl cyclase I regulates AMPA receptor trafficking during mouse cortical 'barrel' map development. Nat Neurosci 6, 939-947.
71. Lyons, W.E., Mamounas, L.A., Ricaurte, G.A., Coppola, V., Reid, S.W., Bora, S.H., Wihler, C., Koliatsos, V.E. & Tessarollo, L. (1999) Brain-derived neurotropic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. PNAS 96, 15239-15244.
72. MacQueen, G.M., Ramakrishnan, K., Croll, S.D., Siuciak, J.A., Yu, G., Young, L.T. & Fahnestock, M. (2001) Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115, 1145-1153.
73. Maier, D.L., Mani, S., Donovan, S.L., Soppet, D., Tessarollo, L., McCasland, J.S. & Meiri, K.F. (1999) Disrupted cortical map and absence of cortical barrels in growth-associated protein (GAP) -43 knockout mice. Proc Natl Acad Sci U S A 96, 9397-9402.
74. Mamounas, L.A., Blue, M.E., Siuciak, J.A. & Altar, C.A. (1995) Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15, 7929-7939.
75. Manuck, S.B., Flory, J.D., Ferrell, R.E., Mann, J.J. & Muldoon, M.F. (2000) A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 95, 9-23.
76. Mathews, T.A., Fedele, D.E., Unger, E.L., Lesch, K.-P., Murphy, D.L. & Andrews, A.M. (2000) Effects of serotonin transporter inactivation on extracellular 5-HT levels in vivo microdialysis recovery and MDMA-induced release of serotonin and dopamine in mouse striatum. Abstract, Society of Neuroscience 26, 624.3, 1666.
77. Mazzanti, C.M., Lappalainen, J., Long, J.C., Bengel, D., Naukkarinen, H., Eggert, M., Virkkunen, M., Linnoila, M. & Goldman, D. (1998) Role of the serotonin transporter promoter polymorphism in anxiety related traits. Arch General Psychiatry 55, 936-940.
78. McDougle, C.J., Epperson, C.N., Price, L.H. & Gelernter, J. (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3, 270-273.
79. Messer, A., Eisenberg, B. & Plummer, J. (1991) The Lurcher cerebellar mutant phenotype is not expressed on a staggerer mutant background. J Neurosci 11, 2295-2302.
80. Mill, J., Asherson, P., Browes, C., D'Souza, U. & Craig, I. (2002) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114, 975-979.
81. Miller, G.M., Yatin, S.M., De La Garza, R.N., Goulet, M. & Madras, B.K. (2001) Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res Mol Brain Res 87, 124-143.
82. Montanez, S., Owens, W.A., Gould, G.G., Murphy, D.L. & Daws, L.C. (2003) Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem 86, 210-219.
83. Moore, K.J. & Nagle, D.L. (2000) Complex trait analysis in the mouse: The strengths, the limitations and the promise yet to come. Annu Rev Genet 34, 653-686.
84. Murphy, D.L., Li, Q., Engel, S., Wichems, C., Andrews, A., Lesch, K.P. & Uhl, G. (2001) Genetic perspectives on the serotonin transporter. Brain Res Bull 56, 487-494.
85. Murphy, V.E., Mynett-Johnson, L.A., Claffey, E., Bergin, P., McAuliffe, M., Kealey, C. & McKeon, P. (2000) Search for bipolar disorder susceptibility loci: the applications of a modified genome scan concentrating on gene-rich regions. Am J Med Genet 96, 728-732.
86. Murphy, D.L., Sims, K.B., Karoum, F., de la Chapelle, A., Norio, R., Sankila, E.M. & Breakefield, X.O. (1990) Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. J Neurochem 54, 242-247.
87. Murphy, D.L., Wichems, C., Li, Q. & Heils, A. (1999) Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends Pharmacol Sci 20, 246-252.
88. Mynett-Johnson, L., Kealey, C., Claffey, E., Curtis, D., Bouchier-Hayes, L., Powell, C. & McKeon, P. (2000) Multimarkerhaplo-types within the serotonin transporter gene suggest evidence of an association with bipolar disorder. Am J Med Genet 96, 845-849.
89. Nadeau, J.H. (2001) Modifier genes in mice and humans. Nat Rev Genet 2, 165-174.
90. Nakagawa, T., Ogawa, Y., Ebihara, K., Yamanaka, M., Tsuchida, A., Taiji, M., Noguchi, H. & Nakao, K. (2003) Anti-obesity and antidiabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord 27, 557-565.
91. Nakagawa, T., Ono-Kishino, M., Sugaru, E., Yamanaka, M., Taiji, M. & Noguchi, H. (2002) Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Diabetes Metab Res Rev 18, 185-191.
92. Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F. & Kennedy, J.L. (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71, 651-655.
93. Ogawa, S., Chester, A.E., Hewitt, S.C., Walker, V.R., Gustafsson, J.A., Smithies, O., Korach, K.S. & Pfaff, D.W. (2000) Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO). Proc Natl Acad Sci U S A 97, 14737-14741.
94. Ohno, Y., Tanase, H., Nabika, T., Otsuka, K., Sasaki, T., Suzawa, T., Morii, T., Yamori, Y. & Saruta, T. (2000) Selective genotyping with epistasis can be utilized for a major quantitative trait locus mapping in hypertension in rats. Genetics 155, 785-792.
95. Ozaki, N., Goldman, D., Kaye, W.H., Plotnicov, K., Greenberg, B.D., Lappalainen, J., Rudnick, G. & Murphy, D.L. (in press) Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry.
96. Pan, Y., Gembom, E., Peng, W., Lesch, K.P., Mossner, R. & Simantov, R. (2001) Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res 126, 125-129.
97. Pelleymounter, M.A., Cullen, M.J. & Wellman, C.L. (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131, 229-238.
98. Persico, A.M., Baldi, A., Dell'Acqua, M.L., Moessner, R., Murphy, D.L., Lesch, K.P. & Keller, F. (2003) Reduced programmed cell death in brains of serotonin transporter knockout mice. Neuroreport 14, 341-344.
99. Persico, A.M., Mengual, E., Moessner, R., Hall, F.S., Revay, R.S., Sora, I., Arellano, J., DeFelipe, J., Gimenez-Amaya, J.M., Conciatori, M., Marino, R., Baldi, A., Cabib, S., Pascucci, T., Uhl, G.R., Murphy, D.L., Lesch, K.P., Keller, F. & Hall, S.F. (2001) Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 21, 6862-6873.
100. Phillips, P.C. (1996) Waiting for a compensatory mutation: phase zero of the shifting-balance process. Genet Res 67, 271-283.
101. Phillips, P.C. & Johnson, N.A. (1998) The population genetics of synthetic lethals. Genetics 150, 449-458.
102. Plomin, R., Owen, M.J. & McGuffin, P. (1994) The genetic basis of complex human behaviors. Science 264, 1733-1739.
103. Pozzo-Miller, L.D., Gottschalk, W., Zhang, L., Du McDermott, K.J., Gopalakrishnan, R., Oho, C., Sheng, Z.H. & Lu, B. (1999) Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 19, 4972-4983.
104. Rankinen, T., Perusse, L., Rauramaa, R., Rivera, M.A., Wolfarth, B. & Bouchard, C. (2001) The human gene map for performance and health-related fitness phenotypes. Med Sci Sports Exerc 33, 855-867.
105. Ravary, A., Muzerelle, A., Darmon, M., Murphy, D.L., Moessner, R., Lesch, K.P. & Gaspar, P. (2001) Abnormal trafficking and subcellular localization of an N-terminally truncated serotonin transporter protein. Eur J Neurosci 13, 1349-1362.
106. Rhoades, R.W., Bennett-Clarke, C.A., Shi, M.Y. & Mooney, R.D. (1994) Effects of 5-HT on thalamocortical synaptic transmission in the developing rat. J Neurophysiol 72, 2438-2450.
107. Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., Lechan, R.M. & Jaenisch, R. (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15, 1748-1757.
108. Rioux, A., Fabre, V., Lesch, K.P., Moessner, R., Murphy, D.L., Lanfumey, L., Hamon, M. & Martres, M.P. (1999) Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci Lett 262, 113-116.
109. Robinson, S.W., Dinulescu, D.M. & Cone, R.D. (2000) Generic models of obesity and energy balance in the mouse. Annu Rev Genet 34, 687-745.
110. 1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-HT transporter knockout mice. J Neurosci 21, 884-896.
111. Samochowiec, J., Lesch, K.P., Rottmann, M., Smolka, M., Syagailo, Y.V., Okladnova, O., Rommelspacher, H., Winterer, G., Schmidt, L.G. & Sander, T. (1999) Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res 86, 67-72.
112. Saudou, F., Amara, D.A., Dierich, A., LeMeur, M., Ramboz, S., Segu, L., Buhot, M.C. & Hen, R. (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265, 1875-1878.
113. Schmitt, A., Mossner, R., Gossmann, A., Fischer, I.G., Gorboulev, V., Murphy, D.L., Koepsell, H. & Lesch, K.P. (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71, 701-709.
114. Seong, E., Seasholtz, A.F. & Burmeister, M. (2002) Mouse models for psychiatric disorders. Trends Genet 18, 643-650.
115. Sims, K.B., de la Chapelle, A., Norio, R., Sankila, E.M., Hsu, Y.P.P., Rinehart, W.B., Corey, T.J., Ozelius, L., Powell, J.F., Bruns, G., Gusella, J.F., Murphy, D.L. & Breakefield, X.O. (1989) Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron 2, 1069-1076.
116. Siuciak, J.A., Boylan, C., Fritsche, M., Altar, C.A. & Lindsay, R.M. (1996) BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 710, 11-20.
117. Sklar, P., Gabriel, S.B., McInnis, M.G., Bennett, P., Lim, Y.M., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., DePaulo, J.R. & Lander, E.S. (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7, 579-593.
118. Sora, I., Hall, F.S., Andrews, A.M., Itokawa, M., Li, X.-F., Wei, H.-B., Wichems, C., Lesch, K.-P., Murphy, D.L. & Uhl, G.R. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. PNAS 98, 5300-5305.
119. Sora, I., Wichems, C., Takahashi, N., Li, X.F., Zeng, Z., Revay, R., Lesch, K.P., Murphy, D.L. & Uhl, G.R. (1998) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 95, 7699-7704.
120. Stephan, W. (1996) The rate of compensatory evolution. Genetics 144, 419-426.
121. Tachida, H. & Cockerham, C.C. (1989) A building block model for quantitative genetics. Genetics 121, 839-844.
122. Terauchi, Y., Iwamoto, K., Tamemoto, H., Komeda, K., Ishii, C., Kanazawa, Y., Asanuma, N., Aizawa, T., Akanuma, Y., Yasuda, K., Kodama, T., Tobe, K., Yazaki, Y. & Kadowaki, T. (1997) Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 99, 861-866.
123. Uhl, G.R., Hall, F.S. & Sora, I. (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7, 21-26.
124. Uhl, G.R., Liu, Q.R., Walther, D., Hess, J. & Naiman, D. (2001) Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet 69, 1290-1300.
125. Upton, A.L., Ravary, A., Salichon, N., Moessner, R., Lesch, K.P., Hen, R., Self, I. & Gaspar, P. (2002) Lack of 5-HT (1 B) receptor and of serotonin transporter have different effects on the segregation of retinal axons in the lateral geniculate nucleus compared to the superior colliculus. Neuroscience 111, 597-610.
126. Upton, A.L., Salichon, N., Lebrand, C., Ravary, A., Blakely, R., Seif, I. & Gaspar, P. (1999) Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J Neurosci 19, 7007-7024.
127. Vallone, D., Pignatelli, M., Grammatikopoulos, G., Ruocco, L., Bozzi, Y., Westphal, H., Borrelli, E. & Sadile, A.G. (2002) Activity, non-selective attention and emotionality in dopamine D2/ D3 receptor knock-out mice. Behav Brain Res 130, 141-148.
128. Vitalis, T., Cases, O., Callebert, J., Launay, J.M., Price, D.J., Seif, I. & Gaspar, P. (1998) Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J Comp Neurol 393, 169-184.
129. Vogel, C., Mossner, R., Gerlach, M., Heinemann, T., Murphy, D.L., Riederer, P., Lesch, K.P. & Sommer, C. (2003) Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci 23, 708-715.
130. Wagner, G.P., Laubichler, M.D. & Bagheri-Chaichian, H. (1998) Genetic measurement of theory of epistatic effects. Genetica 102-103, 569-580.
131. Watase, K. & Zoghbi, H.Y. (2003) Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet 4, 296-307.
132. van Wezel, T., Stassen, A.P., Moen, C.J., Hart, A.A., van der Valk, M.A. & Demant, P. (1996) Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet 14, 468-470.
133. Wisor, J.P., Wurts, S.W., Hall, F.S., Lesch, K.P., Murphy, D.L., Uhl, G.R. & Edgar, D.M. (2003) Altered rapid eye movement sleep timing in serotonin transporter knockout mice. Neuroreport 14, 233-238.
134. Wong, J.Y., Clifford, J.J., Massalas, J.S., Kinsella, A., Waddington, J.L. & Drago, J. (2003) Essential conservation of D (1) mutant phenotype at the level of individual topographies of behaviour in mice lacking both D (1) and D (3) dopamine receptors. Psychopharmacology (Berl) 167, 167-173.
135. Xu, F., Gainetdinov, R.R., Wetsel, W.C., Jones, S.R., Bohn, L.M., Miller, G.W., Wang, Y.M. & Caron, M.G. (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3, 465-471.
136. Zhou, F.C., Lesch, K.P. & Murphy, D.L. (2002) Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942, 109-119.